Vesugen vs Cartalax
Side-by-side comparison of Vesugen and Cartalax: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Vesugen
Cartalax
Vesugen
Vesugen is a short synthetic peptide developed within Vladimir Khavinson's laboratory at the Saint Petersburg Institute of Bioregulation and Gerontology and marketed in Russia as an oral capsule for vascular and…
Lowest listed price: $49.99 across 1 listing
Full Vesugen profileCartalax
Cartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, positioned as a "cartilage bioregulator" intended to…
Lowest listed price: $58.85 across 3 listings
Full Cartalax profileSide-by-side comparison
| Attribute | Vesugen | Cartalax |
|---|---|---|
| Category | Recovery | Recovery |
| Research Stage | Preclinical | Preclinical |
| Mechanism of Action | Vesugen's proposed mechanism follows the three-stage Khavinson short-peptide framework. At the pharmacokinetic level, oral dosing is claimed to produce sufficient intact peptide absorption to deliver bioactive quantities to target tissues. Mechanistic work… | Mechanism of Action Cartalax's proposed mechanism is the Khavinson short-peptide framework applied to cartilage: passive membrane permeation, nuclear import, and sequence-selective chromatin modulation producing chondrocyte-favourable transcriptional shifts.… |
| Half-Life | Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published. | No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured. |
| Typical Dose Range | 20 mg oral capsule 1-2 daily for 10-day cycles (60-90 day washout) | 20 mg oral/sublingual once daily for 10 days; 60-90 day washout |
| Dosing Frequency | 1-2 capsules daily during the 10-day cycle | Once daily |
| Administration | — | — |
| Side Effects | Published Khavinson-group observations describe Vesugen as well tolerated at the recommended oral dose of 1 to 2 capsules daily during a 10-day cycle. Specific adverse events noted include occasional mild gastrointestinal discomfort (nausea, loose stools)… | Side Effects and Safety Cartalax has been used in Russian clinical settings for roughly 20 years with a sparse adverse-event literature — reassuring in direction, insufficient for confident pharmacovigilance. Reported short-term adverse effects -… |
| Molecular Weight | 390.39 g/mol | 333.29 g/mol |
| Common Vial Sizes | — | — |
Price tracking
Price History
3 data points- Ion Peptide
- Disguised Alpha
- LB
Vesugen: potential benefits
- Vascular health support
- Blood vessel integrity maintenance
- Endothelial function optimization
- Cardiovascular anti-aging
Cartalax: potential benefits
- Joint and cartilage repair support
- Connective tissue maintenance
- Anti-aging effects on musculoskeletal system
- Improved joint mobility
Frequently asked
What's the difference between Vesugen and Cartalax?
Vesugen is a recovery that vesugen's proposed mechanism follows the three-stage khavinson short-peptide framework. at the pharmacokinetic level, oral dosing is claimed to produce sufficient intact peptide…. Cartalax is a recovery that mechanism of action cartalax's proposed mechanism is the khavinson short-peptide framework applied to cartilage: passive membrane permeation, nuclear import, and sequence-selective…. The two differ in mechanism, half-life (Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published. vs No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured.), and typical dose range.
Which has the longer half-life, Vesugen or Cartalax?
Vesugen has a half-life of Not established in humans. As a short tripeptide, KED is expected to be rapidly hydrolyzed in plasma, with an anticipated half-life on the order of minutes; no formal pharmacokinetic study of Vesugen has been published.. Cartalax has a half-life of No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Which is cheaper, Vesugen or Cartalax?
Lowest listed price on BodyHackGuide: Vesugen from $49.99, Cartalax from $58.85. Prices are pulled from the vendor listings tracked on BHG and change frequently. See the compare tables on each compound page for the current set of offers.
Can you stack Vesugen and Cartalax?
Stacking depends on mechanism overlap, safety profile, and goals. Vesugen and Cartalax should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Vesugen or Cartalax
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.